Effox provides long-term treatment of coronary artery diseases (ex: Angina pectoris), its is composed of Isosorbide mononitrate; unlike dinitrates it has no first pass metabolism , thus providing 100% Bioavailability with an onset of action within 20 minutes of administration, and a dose of one tablet twice daily.
Packaging: 20 tablets
In the Most recent Guidelines of the European Society of Cardiology (SCAD) for the management of Stable Coronary Aretry Disease (SCAD);
Nitrates were recommended for the relief of Angina/ Ischaemia.
Deponit is the latest generation in transdermal nitrate patches, manufactured with high technology to provide optimum compliance to the patient with minimal patch size and thickness, together with consistent nitrate release.
Isosorbide-5-mononitrate 50 mg for the management of coronary aretry disease. In biphasic release formulation, 30% immediate release & 70% sustained release to provide risk adjusted protection with once daily dosage and nitrate free interval.
Lipanthyl 300 is recommended for the treatment of hypercholesterolaemia (abnormally elevated levels of cholesterol in blood) and/or hypertriglyceridaemia (abnormally elevated levels of triglycerides).
The meeting was chaired by Prof. Abdel-Shakour EL MOHAMADY.
New Horizons in sport medicine were discussed in a meeting
Minapharm launched a new form of Hair Plus back; Topical
MINAPHARM announces the launch of the first minoxidil 5% foam in Egypt, Hair Plus Back Topical foam, prescribed in various types of alopecia and hair loss.
Stay connected, subscribe to our newsletter for news and updates.